Mantis takes disparate sources of data to make synthetic datasets that can be used to build so-called "digital twins" of the ...

On one side, operations and quality leaders are under pressure to deploy machine learning that can meaningfully reduce ...

Explore how life-science companies adapt office spaces to balance hybrid work flexibility with the need for innovation, ...

A chicken egg at Neion Bio, a biotech start-up, receiving a microinjection. The company aims to to turn chicken eggs into ...

Streamlining clinical trials, harmonising regulations and improving access to capital should be driving biotech efforts, ...

Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced ...

The biotech industry needs to stop waiting for a rebound. The pandemic changed everything, though not in the ways most people ...

The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new ...

This royalty-focused biotech with a broad drug portfolio reported a notable insider sale amid strong stock performance.

Anthropic has acquired Coefficient Bio, a stealth biotech startup with fewer than 10 people, for $400 million in stock. The ...

Despite world-class AI-biotech research, a Nobel Prize-winning protein design lab and proximity to global AI expertise, Washington's life sciences sector is still learning to tell its story.

Christine Allen, CEO and Co-Founder of Intrepid Labs, and Andy Lewis, CSO at Quotient Sciences, highlight their strategic ...